Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Cellular Biomedicine (CBMG)

Cellular Biomedicine (CBMG)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
19.75 unch (unch) 02/19/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 19.75 unch (unch) -
Quote Overview for Fri, Feb 19th, 2021
Day Low
19.73
Day High
19.75
Open 19.74
Previous Close 19.75 19.75
Volume 171,900 171,900
Avg Vol 197,580 197,580
Stochastic %K 98.46% 98.46%
Weighted Alpha +21.75 +21.75
5-Day Change +0.02 (+0.10%) +0.02 (+0.10%)
52-Week Range 11.48 - 19.75 11.48 - 19.75
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 384,691
  • Shares Outstanding, K 19,478
  • Annual Sales, $ 340 K
  • Annual Income, $ -49,980 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.17
  • Price/Sales 1,184.26
  • Price/Cash Flow N/A
  • Price/Book 22.15
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.82
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/26/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.60 +12.22%
on 01/28/21
Period Open: 18.16
19.75 -0.03%
on 02/18/21
+1.59 (+8.76%)
since 01/19/21
3-Month
17.60 +12.22%
on 01/28/21
Period Open: 18.35
19.75 -0.03%
on 02/18/21
+1.40 (+7.63%)
since 11/19/20
52-Week
11.48 +72.04%
on 03/16/20
Period Open: 16.87
19.75 -0.03%
on 02/18/21
+2.88 (+17.07%)
since 02/19/20

Business Summary

Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments...

See More

Key Turning Points

3rd Resistance Point 19.78
2nd Resistance Point 19.76
1st Resistance Point 19.76
Last Price 19.75
1st Support Level 19.74
2nd Support Level 19.72
3rd Support Level 19.72

See More

52-Week High 19.75
Last Price 19.75
Fibonacci 61.8% 16.59
Fibonacci 50% 15.62
Fibonacci 38.2% 14.64
52-Week Low 11.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar